Investors Sue Drug Maker Over Clinical Study Result Misrepresentations

Mealey's (October 17, 2016, 12:24 PM EDT) -- BOSTON — A pharmaceutical company and certain of its executive officers and directors and others misrepresented the success of clinical test results for the company’s prostate cancer drug in violation of...

To view the full article, register now.